Owkin Announces Partnership with AstraZeneca to Develop an AI gBRCA Pre-Screen Solution for Breast Cancer

PARIS–( SERVICE CORD)– Owkin, the very first end-to-end AI-biotech that utilizes sophisticated causal AI to unlock accuracy medication exploration, growth and diagnostics, delights in to introduce a brand-new collaboration with AstraZeneca, an international biopharmaceutical firm, to create an AI-powered device to pre-screen for gBRCA anomalies (gBRCAm) in bust cancer cells straight from digitized pathology slides. As component of Owkin’s continuous cooperation with Gustave Roussy and The Centre Léon Bérard with Picture, a Fre

发布者:Dr.Durant,转转请注明出处:https://robotalks.cn/owkin-announces-partnership-with-astrazeneca-to-develop-an-ai-gbrca-pre-screen-solution-for-breast-cancer/

(0)
上一篇 2 10 月, 2024
下一篇 2 10 月, 2024

相关推荐

发表回复

您的电子邮箱地址不会被公开。 必填项已用 * 标注

联系我们

400-800-8888

在线咨询: QQ交谈

邮件:admin@example.com

工作时间:周一至周五,9:30-18:30,节假日休息

关注微信
社群的价值在于通过分享与互动,让想法产生更多想法,创新激发更多创新。